Are cardiovascular and sympathoadrenal effects of human "New Pressor Protein" preparations attributable to human coagulation {beta}-FXIIa?

PC Papageorgiou; A Pourdjabbar; AA Amfilochiadis; EP Diamandis; Frans Boomsma; DH Osmond

Are cardiovascular and sympathoadrenal effects of human "New Pressor Protein" preparations attributable to human coagulation {beta}-FXIIa?

PC Papageorgiou, A Pourdjabbar, AA Amfilochiadis, EP Diamandis, Frans Boomsma, DH Osmond

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	837-846
Number of pages	10
Journal	American Journal of Physiology-Heart and Circulatory Physiology
Volume	286
Publication status	Published - 2004

Cite this

@article{5d394722ff754cb193b534dd2ee1d7d3,

title = "Are cardiovascular and sympathoadrenal effects of human {"}New Pressor Protein{"} preparations attributable to human coagulation {beta}-FXIIa?",

author = "PC Papageorgiou and A Pourdjabbar and AA Amfilochiadis and EP Diamandis and Frans Boomsma and DH Osmond",

year = "2004",

language = "Undefined/Unknown",

volume = "286",

pages = "837--846",

journal = "American Journal of Physiology-Heart and Circulatory Physiology",

issn = "0363-6135",

publisher = "American Physiological Society",